HOME › DRUGS › NABUMETONE
ACTIVE SUBSTANCE / INN

NABUMETONE

Brand name(s): NABUMETONE, RELAFEN
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA090516
NDA019583
ACTIVE SUBSTANCE
Nabumetone
REGULATORS
FDA
SPONSORS / MAH
SMITHKLINE BEECHAM, NOVITIUM PHARMA, AUROBINDO PHARMA USA
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NABUMETONEANDA090516AUROBINDO PHARMA USADiscontinued
RELAFENNDA019583SMITHKLINE BEECHAMDiscontinued
NABUMETONEANDA219118NOVITIUM PHARMAPrescription

FULL INTELLIGENCE ON NABUMETONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →